Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.78
Delayed Data
As of Dec 02
 -0.02 / -2.50%
Today’s Change
0.29
Today|||52-Week Range
1.12
+11.43%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.80
Today’s open0.82
Day’s range0.76 - 0.82
Volume81,756
Average volume (3 months)248,215
Market cap$124.2M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book58.91

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...-0.10-3.51%
SMMTSummit Therapeutics ...+0.01+0.08%
CORICorium International...+0.32+6.30%
CTRVContraVir Pharmaceut...+0.01+0.50%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Class I Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts


Search for Jobs